PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Crawls 10,000+ sources around the clock and organizes the noise into verified stories — de-duplicated, bias-scored, and auto-tagged, with blindspot detection, trend analytics, anomaly alerts, translation, and custom digests or RSS. All in one live dashboard.

GeekWire

techLeft

7h ago

Seattle biotech BrainChild Bio raises $116M to advance CAR T therapy for childhood brain cancertranslating…

Seattle biotech BrainChild Bio has raised $116 million to advance an experimental CAR T cell therapy for DIPG, a rare and deadly brain tumor that primarily affects young children. The company is building on technology developed at Seattle Children’s and is also developing CAR T…

Factuality

74/100

Political Bias

Left

Ownership

GeekWire LLC

Country

USA

Region

North America

Language

English

Keywords#CAR#Seattle#BrainChild Bio#CAR T#seattle biotech

Read Original ↗

Seattle biotech BrainChild Bio raises $116M to advance CAR T therapy for childhood brain cancer | Pulse Aggregator